A shadow market for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on communication apps, according to new investigations.
The experimental drug, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning properties. Followers are urged to message these accounts privately for source information, while also obtaining discount codes.
Additionally, a robust market exists on messaging services, where groups with numerous of participants share comparison photos, injection guides and claims of rapid UK delivery. Vendors promote the substance there before redirecting buyers to WhatsApp for purchases.
This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.
However, doctors and chemists have cautions that the distribution of what is still an unlicensed drug in the UK is worrisome and could lead to users administering substances of unknown origin.
Some professionals stated the popularity for retatrutide could be connected to the rising cost of approved weight loss products such as Mounjaro.
Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate pharmaceutical, marketing, and customer laws, risking penalties, legal action or prison.
According to the social media company, the platform has taken down problematic material and prohibited associated keywords and query recommendations. The organization said it was committed to keeping the platform safe and allocating resources in strengthening enforcement strategies.
Investigations also found groups with up to 9,000 members marketing the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with numerous of members, populated with images of slimming results, glowing testimonials and step-by-step guides for mixing or administering at home.
After moments of entering one group, a seller posted contact information, where the majority of transactions take place. The vendor sent an guidebook and promised shipping within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None asked about weight, medical conditions or previous experience.
Inside these groups, messages show black plastic packages with Royal Mail stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled injectors typically priced at £160 for 20 milligrams. When questioned how much time a pen should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.
A spokesperson for the messaging service said it actively moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
“People are administering substances they cannot confirm. Even if the research behind retatrutide is valid, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service connected the surge in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, patients are using social media. But fake injections are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was clean,” she said.
Her staff has previously seen patients harmed by personal administration from unverified sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be impure or incorrectly dosed.”
A spokesperson from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a company investigational product not yet approved … may expose patients to possibly significant health risks”.
A seasoned journalist with a passion for uncovering stories that matter in the Czech Republic and beyond.
